Woman wearing a headscarf resting in bed under a blue blanket during cancer treatment

Prescription Drugs Linked to Cancer According to Lawsuits

Updated October 24, 2026

When a prescription drug is later linked to cancer, the people who took it often turn to the courts. These lawsuits usually claim that a drug company knew or should have known about a cancer risk and did not warn patients and doctors, or that a medication was contaminated with a cancer-causing chemical during manufacturing.

This guide covers the main prescription drug cancer lawsuits now in the courts: what each one claims, where the cases stand, and what people who took these drugs should know.

Dupixent and T-Cell Lymphoma

Dupixent (dupilumab), made by Regeneron and Sanofi, is an injectable drug for eczema, asthma and several other conditions. Lawsuits allege that it can cause or speed up cutaneous T-cell lymphoma (CTCL), a rare cancer that starts in white blood cells and shows up first in the skin. Because early CTCL can look like eczema, the lawsuits also allege the drug can hide the cancer while it grows.

On June 4, 2026, the federal Dupixent cases were grouped into one proceeding, MDL No. 3180, before U.S. District Judge Zahid N. Quraishi in New Jersey. As of October 1, 2026, 38 cases were pending there, with more in New Jersey state court. LegalScoops covers the latest in Dupixent lymphoma lawsuits grow as cases head to New Jersey and an early Dupixent wrongful death lawsuit.

Plaintiffs point to a 2024 study in the Journal of the American Academy of Dermatology that found about four times the odds of CTCL among eczema patients treated with Dupixent. The FDA has listed CTCL as a potential safety signal for Dupixent and said it is evaluating the need for regulatory action, but the U.S. label does not warn about lymphoma.

Doyle APC is investigating Dupixent lymphoma lawsuits nationwide for people diagnosed with T-cell lymphoma after using the drug.

Zantac and NDMA

In April 2020, the FDA asked drug makers to pull all ranitidine, sold as Zantac, from the U.S. market after finding that it could contain or form NDMA, a probable human carcinogen. Thousands of Zantac lawsuits followed, claiming the drug caused bladder, stomach, esophageal, liver, pancreatic and other cancers.

The federal cases did not go well for plaintiffs. In December 2022, the judge overseeing the federal MDL in Florida ruled that the plaintiffs’ experts could not testify, which ended most federal claims. That ruling is on appeal to the Eleventh Circuit, which heard argument in October 2025.

Most claims were filed in state courts. In October 2024, GSK agreed to pay up to $2.2 billion to resolve about 80,000 state court cases, and Pfizer and Sanofi settled thousands of cases earlier that year. In Delaware, where more than 80,000 cases were filed, the state supreme court reversed a ruling that had allowed the plaintiffs’ experts to testify, and in April 2026 the trial court granted judgment to the drug makers on the cases filed through December 1, 2025. The plaintiffs have appealed.

Valsartan and Other Blood Pressure Drugs

In July 2018, the FDA announced a recall of valsartan after some generic versions of the blood pressure drug were found to contain NDMA. Recalls later spread to losartan and irbesartan. The impurities were traced to changes in how some overseas manufacturers made the active ingredient.

Federal valsartan cases are grouped in MDL No. 2875 before Chief Judge Renée Marie Bumb in New Jersey, where 1,426 cases were pending on October 1, 2026. In November 2025, the court excluded the plaintiff’s experts and ruled for the manufacturer in the first personal injury bellwether case, which involved liver cancer. That decision is on appeal, and no global settlement has been announced.

Depo-Provera and Brain Tumors

More than 6,400 lawsuits claim that the birth control shot Depo-Provera, made by Pfizer, causes meningioma, a tumor that grows on the lining of the brain and spinal cord. Meningiomas are usually not cancer, but they can require surgery and cause lasting harm. The federal cases are grouped in MDL No. 3140 before Judge M. Casey Rodgers in Florida. LegalScoops has covered the Depo-Provera brain tumor lawsuits.

Other Prescription Drug Lawsuits

Not every major drug lawsuit involves cancer. GLP-1 weight loss and diabetes drugs such as Ozempic, Wegovy and Mounjaro face more than 4,000 federal lawsuits over stomach paralysis and other digestive injuries, and a separate federal MDL created in December 2025 handles claims that the drugs caused NAION, a sudden loss of vision in one eye. Doyle APC is investigating GLP-1 vision loss claims.

How These Lawsuits Work

Most prescription drug cancer cases are mass torts, not class actions. Each person files an individual claim, and federal cases from around the country are grouped before one judge in a multidistrict litigation (MDL) for evidence gathering and early rulings. LegalScoops explains the difference in mass tort vs. class action.

The key question in nearly every drug case is general causation: whether the science shows the drug can cause the cancer at all. Courts decide whether each side’s experts on that question may testify, and those rulings often decide whether the litigation moves forward, as the Zantac and valsartan cases show.

What Compensation Can Cover

In drug injury claims, compensation can include past and future medical expenses, pain and suffering, loss of enjoyment of life and a spouse’s loss of companionship (loss of consortium). When a person has died, family members may be able to bring a wrongful death claim.

Deadlines to File

Every state has a statute of limitations, the deadline for filing a claim. In drug cases it often runs from the date of diagnosis or from when a person learned the cancer may be linked to the drug. The deadlines vary by state and can be short, so people who suspect a link should have a claim reviewed promptly.

Common Questions About Prescription Drug Cancer Lawsuits

Which prescription drugs are linked to cancer in current lawsuits?

The largest current cases involve Dupixent (T-cell lymphoma), Zantac (bladder, stomach and other cancers from NDMA) and valsartan (cancers from NDMA contamination). Depo-Provera lawsuits involve meningioma, a brain tumor that is usually not cancer.

Is there a class action for drugs that cause cancer?

Most of these cases are mass torts, not class actions. Each person files an individual claim, and the federal cases are grouped before one judge for pretrial proceedings.

Can I file a claim if the drug is still on the market?

Yes. A drug does not have to be recalled for a claim to be filed. Dupixent remains on the market, and the lawsuits focus on whether the companies adequately warned about the cancer risk.

Should I stop taking my medication?

Do not stop a prescribed medication without talking to your doctor. Stopping some drugs suddenly can be dangerous, and your doctor can help weigh the risks and benefits.

What records help show a drug cancer claim?

Pharmacy records showing which drug you took and when, and medical records showing your cancer diagnosis, are the core of most claims. A lawyer reviewing the claim can usually request these records for you.

Diagnosed With Lymphoma After Using Dupixent?

Doyle APC helps people and families nationwide. You pay nothing unless we recover.

Dupixent Case Review (LegalScoops)

By submitting your number, you consent to texts about your inquiry from Doyle APC and the law firms it works with, including autodialed texts. Consent is not required for services. Msg frequency varies. Msg & data rates may apply. Reply STOP to opt out.

Doyle APC is a BBB Accredited Business with an A+ rating (opens in a new tab)